"However, given the demand, the UK must also use its diplomatic leverage with Gilead to demand the three asks outlined in MSF’s campaign and ensure licensing arrangements that put people and communities first, ensuring lenacapavir is affordable and available in every country where it is needed, not just in the markets that are most profitable."
Framing: assertive ·
First seen: 2026-08-21 ·
Last seen: 2026-08-21 ·
Spread: 1 articles